Table 4.

The characteristics of patients diagnosed with follicular thyroid cancer according to their mutational status.

Characteristics	TP53+ or TP53-, FLT3+, RET- n = 16	Other Mutational Status n = 19	p-Value
Male/female, n (%)	2/14 (12.5%/87.5%)	2/17 (10.5%/89.5%)	1.0000
Median age at diagnosis, years (range)	50 (27–81)	56 (27–82)	0.4560
Age group (≤60 years/>60 years), n (%)	3/13 (18.75%/81.25%)	7/12 (36.8%/63.2%)	0.2853
Median length of follow-up, months (range)	108 (17–130)	116 (28–144)	0.5674
Multifocality, n (%)	2 (12.5%)	2 (10.5%)	1.0000
Capsule invasion, n (%)	5 (31)	9 (47)	0.3322
Extracapsular extension, n (%)	9 (56.3%)	9 (47.4%)	0.6005
Nodal (N) involvement, n (%)	1 (6.3%)	3 (15.8%)	0.6081
Mean tumor size, mm (range)	32 (7–75)	29 (12–18)	0.6737
Tumor diameter ≤10 mm, n (%)	1 (6.3%)	1 (5.3%)	1.0000
Localization in the right/left/both lobes, n (%)	7/2/7 (43.8%/12.5%/43.8%)	10/1/8 (52.6%/5.3%/42.1%)	0.8844
Chronic lymphocytic thyroiditis n (%)	2 (12.5%)	5 (26.3%)	0.4150
Radioactive iodine-refractoriness n (%)	0 (0.0%)	2 (10.5%)	0.4891

The p-values were based on chi-square test (or Fisher’s exact test when appropriate) for categorical variables and Mann–Whitney U test for quantitative variables.